Revenue FY2025
$150.0M
Net Income
$(75.0M)
EPS (Basic)
$-1.18
Net Margin
-49.9%
ROE
-134.2%
Total Equity
$56.0M
Shares Out
64M
MACROGENICS INC — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2011–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
RA Capital Management
RA Capital Management
$8.6M
0.1%
—
Renaissance Technologies
Renaissance Technologies
$12.2M
0.0%
(11.2%)
Insider Transactions
Reading stored insider transactions…